Digital health is all the rage in Silicon Valley, especially as consumer technology’s biggest players are getting more interested in tracking health and fitness. But for companies like iRhythm, the health side of the equation comes first.
iRhythm Technologies Inc.
HistoSonics pulls in $14M | Medtech funding for the week of May 19, 2014
mHealth: iRhythm raises $17M for Zio wearable monitor
Remote monitoring startup iRhythm touted a new $17 million Series E funding round in support of its wearable devices, saying it plans to pursue efforts in commercialization, marketing and clinical studies.
The San Francisco company offers continuous cardiac monitoring with its FDA-cleared Zio wearable device and accompanying software. The system is designed to log data on patients’ heart rhythms, then process and analyze the data to kick out a report for physicians.
St. Jude-backed iRhythm Technologies raises another $16M for Zio wearable heart monitor
iRhythm Technologies said it closed a $16 million Series D round for its Zio wearable heart monitor, saying it plans to use the proceeds to further its commercial footprint and research & development efforts.
Led by Norwest Venture Partners, which added partner Casper de Clercq to iRhythm’s board, the latest financing including contributions from existing backers New Leaf Ventures, Synergy Life Science Partners and Kaiser Permanente Ventures.
Survey: Heart docs say Edwards on track for solid heart valve growth | Wall Street Beat
Edwards Lifesciences (NYSE:EW) is on track for solid growth in the transcatheter aortic valve implant market, according to a survey of cardiologists conducted by Leerink Swann analysts.
Mako Surgical preps $40M public offering | Wall Street Beat
Mako Surgical (NSDQ:MAKO) said it’s planning to sell some 3 million shares of its own stock in an offering worth about $40 million.*
iRhythm appoints Kevin King president & CEO | Personnel Moves
ACC 2012: Headlines from this week’s American College of Cardiology conference
St. Jude Medical puts more skin in iRhythm Technologies| Acquisitions roundup
St. Jude Medical’s (NYSE:STJ) partnership with a California-based arrhythmia-diagnostic company is going well enough that it recently poured more money into that startup.